In Drosophila, the spliceosomal protein SNF fulfills the functions of two vertebrate proteins, U1 snRNP-U1A and U2 snRNP-U2B0. The structure and sequence of SNF, U1A, and U2B0 are nearly identical with two RNA recognition motifs (RRM) separated by a short linker region, yet they have different RNA-binding properties: U1A binds U1 snRNA, U2B0 binds U2 snRNA, and SNF binds both snRNAs. Structure/function studies on the human proteins have identified motifs in the N-terminal RRM that are critical for RNA-binding specificity but have failed to identify a function for the C-terminal RRM. Interestingly, SNF is chimeric in these motifs, suggesting a basis for its dual specificity. Here, we test the importance of these motifs by introducing site-directed mutations in the snf coding region and examining the effects of these mutations on assembly into the snRNP and on snf function in vivo. We found that an N-terminal RRM mutant protein predicted to eliminate RNA binding still assembles into snRNPs and is capable of rescuing snf 's lethal phenotype only if the normally dispensable C-terminal RRM is present. We also found that the mixed motif in the "RNA-specificity" domain is necessary for SNF's dual function whereas the mixed motif in the U2A9-protein-binding region is not. Finally, we demonstrate that animals carrying a snf mutation that converts SNF from a bifunctional protein to a U1 snRNP-specific protein are viable. This unexpected result suggests that SNF's presence within the U2 snRNP is not essential for splicing.
INTRODUCTION
In eukaryotes, many genes contain blocks of noncoding sequences (introns) that must be removed from nascent transcripts (pre-mRNA) to generate functional RNA molecules+ This processing event, known as RNA splicing, is carried out in the spliceosome, a multicomponent catalytic RNA-protein complex that is assembled in a step-wise fashion on the pre-mRNA from four small nuclear ribonucleoprotein particles (U1, U2, U4/ U6, and U5 snRNPs) and other non-snRNP proteins (reviewed by Moore et al+, 1993; Kramer, 1996; Staley & Guthrie, 1998 )+ Studies in mammalian cells and yeast have shown that the recruitment of the U1 snRNP and the U2 snRNPs to conserved sequences within the intron is among the earliest steps in spliceosome assembly; it is during these early steps that the intron/ exon junctions are defined (reviewed by Adams et al+, 1996; Reed, 1996; Will & Lührmann, 1997) + From these studies, it is clear that targeting of the U1 and U2 snRNPs to the correct positions on the pre-mRNA requires not only base-pairing interactions between the splice sites and the RNA components of the U1 snRNP (U1 snRNA) and the U2 snRNP (U2 snRNA) but also additional protein-protein interactions between snRNP and non-snRNP proteins+ Although these studies suggest that the protein components of the snRNPs play an important role, their individual contributions to function are poorly defined+ Two snRNP proteins, the U1 snRNP-U1A protein and the U2 snRNP-U2B0 protein are among the most extensively studied snRNP proteins, because they are nearly identical in sequence yet they are assembled into different snRNPs+ U1A and U2B0 both consist of two RRM domains (for RNA recognition motif) separated by a short linker region (Burd & Dreyfuss, 1994 )+ Despite their extensive sequence conservation, these two proteins bind different RNAs: U1A binds specifically to stem-loop II of U1 snRNA and U2B0, when bound to its partner protein U2A9, binds specifically to stem-loop IV of U2 snRNA (Lutz-Freyermuth et al+, 1990; Scherly et al+, 1989 Scherly et al+, , 1990a Scherly et al+, , 1990b Scherly et al+, , 1991 )+ The only part of the U1A and U2B0 proteins that is necessary for specific RNA binding is the N-terminal RRM+ Surprisingly, this domain, which is 75% identical between the two proteins, contains only a few key residues that are critical for RNA-binding specificity in vitro (Nagai et al+, 1990; Scherly et al+, 1990a Scherly et al+, , 1990b Scherly et al+, , 1991 Bentley & Keene, 1991; Hall & Stump, 1992; Rimmele & Belasco, 1998 )+ The C-terminal RRM, which is 86% identical between the two proteins, is not necessary for RNA binding and may not even bind RNA (Lu & Hall, 1995) + A mechanism by which these two proteins recognize and bind their different snRNA targets is suggested by a comparison of the co-crystal of the N-terminal RRM domain of U1A protein bound to stem-loop II of U1 snRNA with the co-crystal of the U2B0/U2A9 heterodimer bound to stem-loop IV of U2 snRNA (Oubridge et al+, 1994; Price et al+, 1998 )+ Together these studies suggest that U1A and U2B0 bind their cognate RNAs through a "mutual induced fit" mechanism where both the RNA and the protein become more structured upon binding, thereby allowing the formation of multiple hydrogen-bonding networks between the RNA and the protein+ The basis for snRNA target discrimination by U1A and U2B0 appears to lie in the formation of a different network of RNA-protein interactions; in the case of U2B0, the formation of this network requires its association with the U2A9 protein (Price et al+, 1998 )+ Although the detailed analysis of U1A and U2B0 has served as a paradigm for understanding how proteins with similar RNA recognition motifs have evolved to recognize different RNA-binding targets, little is known about their functions within the snRNPs or even whether their ability to discriminate between their RNA targets is important in vivo+ With the recent identification of the U1A/U2B0 homolog in Drosophila, we can now take a genetic approach to address the relationship between RNA binding, snRNP assembly and function in vivo+ In Drosophila, a single protein encoded by the essential snf (sans-fille) gene carries out the function of both U1A and U2B0 (Harper et al+, 1992; Flickinger & Salz, 1994; Polycarpou-Schwarz et al+, 1996) + Recent studies have shown that SNF is a true bifunctional protein: in vivo, SNF incorporates into both U1 and U2 snRNPs and in vitro, it binds U1 snRNA by itself and, with the addition of either fly extract or the human U2A9 protein, it binds U2 snRNA (Polycarpou-Schwarz et al+, 1996)+ As is the case with the human proteins, the region of the protein necessary for function appears to reside entirely in the N-terminal half of the protein: a deletion allele that removes the C-terminal RRM domain is homozygous viable and fertile, whereas a deletion that removes the entire open reading frame is lethal (Flickinger & Salz, 1994) + An inspection of the sequence of SNF's N-terminal RRM, which is 77% identical to the human U1A and 74% identical to the human U2B0, reveals that SNF is chimeric in regions of the protein known to be important for the differential binding specificity of the human proteins (Fig+ 1)+ These observations have led to the suggestion that SNF is bifunctional, because it contains these mixed motifs (see, e+g+, Price et al+, 1998)+ Using these predictions as a guide, we have introduced mutations into snf 's coding sequence and examined the effect of these mutations on snRNP incorporation and snf function in vivo+ We report that a mutation that encodes a protein predicted to have lost its ability to bind RNA still assembles into both snRNPs and is capable of rescuing snf 's lethal phenotype+ This finding has led us to the discovery that, for this mutant protein to function, the C-terminal domain must be present, suggesting that the C-terminal domain can tether the protein to the snRNP+ In a second set of experiments, we found that key motifs in the RNAbinding specificity region, but not in the U2A9-proteinbinding motif, are important for directing SNF into the appropriate snRNP+ Finally, we show that animals, homozygous for a snf mutation encoding a protein that is excluded from U2 snRNPs, are viable+ This unexpected result raises the possibility that SNF's role within the U2 snRNP is not essential for function of the core splicing machinery but instead is part of a redundant network of proteins necessary for accurate and efficient splicing+
RESULTS

Construction of a snf + minigene that is fully functional in vivo
To initiate an in vivo structure/function analysis, we constructed a snf minigene that replicates the high level of expression seen at the endogenous locus+ This minigene consists of a full-length cDNA sandwiched between snf genomic sequences that include both the snf promoter and the complete 39 untranslated region (UTR) (see Materials and Methods)+ For this and all other constructs, we generated at least three independent transgenic lines to control for variations in expression due to the insertion site+ Six independent transgenic lines carrying the snf ϩ minigene construct (designated as P[snf ϩ ] ) were assayed for function by determining their ability to complement the snf null allele, snf J210 + snf J210 is an unambiguous null allele because it is a deletion of the entire open reading frame (Flickinger & Salz, 1994 )+ Four out of the six snf ϩ transgenes rescued the lethal phenotype when present in a single copy (Table 1) , providing evidence that the snf ϩ minigene provides sufficient levels of expression for viability+ One representative line was chosen for a detailed genetic, biochemical and cytological analysis to assess the function of the transgenic protein more com-pletely+ As indicated in Table 2 , this line complements the lethal phenotype of snf J210 in both males and females+ This confirms that the minigene construct is functional+ To establish that the protein expressed from the minigene construct is localized appropriately, we first examined its protein localization pattern by fluorescent immunolocalization+ Previous studies have shown that the SNF protein, as well as other splicing factors, associate with polytene chromosomes, because premRNAs remain aligned with the site of transcription as they are spliced (Beyer & Osheim, 1988; Amero et al+, 1992; Salz & Flickinger, 1996) + Using similar techniques, we found that SNF ϩ protein produced from the transgene also coats the polytene chromosomes (Fig+ 2C)+ The visualization of the transgenic protein on polytene chromosomes therefore indicates that this pro-FIGURE 1. The SNF protein is similar to the human U1A and U2B0 proteins+ Identical amino acids within the N-terminal and C-terminal RRM domains are indicated by gray dots above the sequence+ Identical amino acids outside of the RRM domains are indicated by black dots+ The most critical residues for differential interactions with the U2A9 protein are indicated by an arrow (f) with the residues required for U2A9 binding boxed in gray and residues that prevent U2A9 binding boxed in black+ The position of the five critical residues (5MER) for differential RNA binding to U1 snRNA versus U2 snRNA stem-loop sequences are indicated by arrows (f), with the U2B0-like residues boxed in gray and U1A-like residues boxed in black+ The position of the mutations discussed in this article are also indicated by arrows (f)+ ϩ protein produced by the minigene is incorporated into both U1 and U2 snRNPs by demonstrating that U1snRNAs and U2snRNAs can be coimmunoprecipitated with antibodies directed against the SNF protein+ In this experiment, fly extracts, in which the sole source of SNF protein is the minigene, were incubated with antibodies directed against the SNF protein and the immunoprecipitated complex tested for the presence of U1 snRNA and U2 snRNA by Northern blot analysis+ As expected, we found that both U1 and U2 snRNAs are immunoprecipitated with SNF To test whether residues essential for RNA binding in vitro are required for snRNP assembly in vivo, we mutated a conserved arginine to a glutamine (R49Q) in snf 's N-terminal RRM (Figs+ 1 and 2A)+ This mutation is predicted to abolish snf 's ability to bind RNA based on two lines of evidence+ First, the equivalent mutation in the human U1A protein (R52Q) abolishes binding to RNA in vitro (Nagai et al+, 1990 )+ Second, the position of this arginine in the cocrystals of both the U1A protein bound to stem-loop II of U1 snRNA and the U2B0/U2A9 heterodimer bound to stem-loop IV of U2 snRNA indicate that it directly contacts the RNA in both structures+ This suggests that this conserved arginine plays a key role in locking the protein onto the RNA and implies that the substitution of glutamine at this position could interfere with RNA binding by disrupting critical RNAprotein contacts (Oubridge et al+, 1994; Price et al+, 1998 Table 1 , a second set of crosses was used to compare the ability of the transgenes to rescue males versus females+ In these crosses, y w snf J210 males carrying a single copy of the transgene were crossed to y w snf J210 /FM7 females and the resulting progeny scored+ The ability of the mutant transgene to rescue was assessed by comparing the number of y w snf J210 /y w snf J210 females and y w snf J210 males carrying the transgene to the number of "expected" animals as determined by the number of y w snf J210 /FM7 females carrying the transgene recovered+ c For the three transgenic constructs that did not rescue the snf J210 lethal phenotype, the results obtained from the cross described in Table 1 are included for completeness+ FIGURE 2. Structure and expression of wild-type and mutant SNF proteins+ A: Schematic of the wild-type SNF protein and the location of the mutations used in this study+ B: Expression and stability of the transgenic proteins were assayed by Western blot analysis of total protein extracts made from adults carrying two copies of the mutant transgene+ Each lane contains ;1+7 fly equivalents; hence their relative levels of protein can be compared to each other+ In lanes 1, 2, and 3, the transgene-bearing animals were homozygous for y w snf J210 + Because snf J210 is a deletion of the entire open reading frame, all the protein detected with the a-SNF antibody is due to expression from the transgenic copy of snf+ In lanes 4 and 5, the transgene-bearing animals were homozygous for y w snf JA2 + Because snf JA2 is missing the epitope recognized by the a-SNF antibody (Habets et al+ 1989; Flickinger & Salz, 1994) , all the protein detected with the antibody is due to expression from the transgenic copy of snf+ C-G: Localization of the transgenic proteins to polytene chromosomes+ Salivary gland chromosomes from animals carrying a single copy of the mutant transgene+ In all the panels, the transgenic animals are also homozygous for snf JA2 /snf JA2 + Because snf JA2 is missing the epitope recognized by the a-SNF antibody, all the protein detected with the antibody is due to expression from the transgenic copy of snf+ at comparable levels to the SNF ϩ transgenic protein, was chosen for further analysis (Fig+ 2B, lanes 1, 2)+ A single copy of this mutant transgene fully rescues the snf J210 lethal phenotype in both males and females, indicating that the snf R49Q mutation does not interfere with snf 's vital function ( Based on these studies, we conclude that, although the arginine at position 49 is likely to be critical for RNA binding in vitro, in vivo, this arginine is not required for either snRNP assembly or function+ A genetic screen to identify regions of the protein that can mediate SNF's assembly into the snRNP Interestingly, the mammalian U1A protein can assemble into a U1 snRNP on a U1 snRNA substrate missing stem-loop II of U1 snRNA + These studies, together with our results, suggest that other contacts between SNF and components of the snRNP are sufficient for snRNP incorporation+ To identify the region of the SNF protein that mediates incorporation into the snRNP in the absence of N-terminal RRM binding activity, we utilized an in vivo genetic strategy+ The advantage of this strategy is that we do not need to predict which part of the molecule provides this function+ In designing the screen, we reasoned that, if a SNF mutant protein failed to incorporate into both snRNPs, it would no longer rescue the snf lethal phenotype+ Therefore, we selected for derivatives of the snf R49Q mutant transgene that failed to rescue the snf J210 lethal phenotype (Fig+ 4) and identified a single derivative that met this criteria+ Sequence analysis showed that this derivative transgene contained both the original R49Q mutation as well as an additional FIGURE 3. Coimmunoprecipitation of snRNAs with transgenic proteins+ The ability of the transgenic proteins to be incorporated into snRNPs was tested by immunoprecipitation of the transgenic protein from whole-fly extracts followed by Northern blotting to detect U1 and U2 snRNAs+ In lane 1 of all panels 1+3 mg total RNA is loaded to serve as a size marker for the Northern blots+ A: Complexes carrying the transgenic proteins were immunoprecipitated with the a-SNF antibody from protein extracts made from adults carrying a single copy of the mutant transgene and are homozygous for snf J210 + B: Complexes carrying the transgenic proteins were immunoprecipitated with the a-SNF antibody from protein extracts made from adults carrying a single copy of the mutant transgene and are homozygous for snf JA2 + Lane 2 is a control to demonstrate that no RNAs are brought down from extracts made from snf JA2 animals that do not contain a transgene+ C: Complexes carrying the transgenic proteins were immunoprecipitated with the a-human U1A antibody from protein extracts made from adults carrying a single copy of the mutant transgene and are homozygous for either snf JA2 or for snf ϩ + As can be seen from lanes 2 and 4, no RNAs are brought down from extracts made from animals without a transgene expressing the human U1A protein+ FIGURE 4. A genetic screen to select for second site mutations in the P[w ϩ ,snf R49Q ] transgene+ The goal of this screen is to isolate second site mutations in the mutant transgene that are no longer able to rescue the lethal phenotype of the null allele, snf J210 + As described in Materials and Methods, males carrying an autosomal copy of the P[w ϩ , snf R49Q ] transgene were fed a mutagen (EMS) and then derivatives of these transgenes were assayed for the presence of a second site mutation, first by the failure to rescue the lethal phenotype of snf J210 and then by sequence analysis+ mutation that produced a stop codon at the beginning of the C-terminal RRM domain (R49QϩQ138Stop; see Figs+ 1 and 2A)+ Because the SNF-specific monoclonal antibody recognizes only the C-terminal RRM (Flickinger & Salz, 1994) , we were not able to directly establish whether the SNF R49QϩQ138Stop mutant protein is expressed at normal levels or whether it is excluded from snRNPs+ However, reverse-transcribed polymerase chain reaction (RT-PCR) analysis shows that the abundance of transcripts from the SNF R49QϩQ138Stop transgene is approximately equal to those from the parent SNF R49Q transgene, strongly implying that a mutant protein is produced (Fig+ 5)+
The results of these experiments demonstrate that, in this genetic background, the C-terminal RRM is necessary for snf 's vital function+ However, the C-terminal RRM is not essential in the context of a wild-type protein: the snf JA2 allele, which encodes a truncated protein missing the C-terminal RRM, is viable (Flickinger & Salz, 1994 )+ Together, these results suggest that, although the N-terminal RRM is sufficient for function, the C-terminal RRM does provide a function that is redundant with the function provided by the N-terminal RRM+ The fact that the N-terminal RRM can function as an isolated domain raises the possibility that the C-terminal RRM can also function as an isolated domain+ To test this, we designed an snf minigene construct where expression of the C-terminal RRM is driven by the endogenous snf promoter (C-RRM only ; see Materials and Methods)+ Three independent transgenic lines were recovered, none of which rescued the snf lethal phenotype (data not shown)+ Although we detected transcripts by RT-PCR analysis at about the same level as with the SNF ϩ transgene, we failed to detect any C-RRM only protein by Western blot analysis or by the more sensitive immunoprecipitation assays (data not shown)+ We cannot, therefore, distinguish whether the failure to rescue the lethal phenotype is due only to protein instability or whether the fragment also lacks an essential activity+
The human proteins retain their snRNP specificity in the fly Does RNA-binding specificity play any role in snRNP assembly in the fly? To address this question, we asked whether its human homologs, which contain C-terminal RRM that are ;80% identical, retained their snRNP specificity when expressed in the fly+ For this experiment, we inserted cDNAs encoding the human U1A (hU1A) and human U2B0 (hU2B0) proteins into snf minigene constructs, generated transgenic animals, and then tested the ability of the human proteins to associate with U1 and/or U2 snRNPs in fly extracts+ Of the seven independent transgenic lines carrying the hU2B0 transgene analyzed, none were found to complement the lethal null phenotype (Table 1) + One transgenic line, which expressed the hU2B0 protein at comparable levels to the SNF ϩ transgenic protein ( Fig+ 2B, lanes 1,4) , was chosen for further analysis+ First, we determined whether hU2B0 retained its snRNP specificity in the fly+ Because the human U2B0 protein is recognized by the same monoclonal antibody that we used to detect the SNF protein, we immunoprecipitated hU2B0 from fly extracts in which the sole source of protein detectable by the anti-SNF antibody is the hU2B0 protein+ To accomplish this we made extracts from transgene bearing adults homozygous for the viable deletion allele, snf JA2 , that is missing the epitope recognized by the anti-SNF antibody (Habets et al+, 1989; Flickinger & Salz, 1994 )+ We found that U2 snRNA, and not U1 snRNA, is coimmunoprecipitated with the hU2B0 protein (Fig+ 3B, lane 5), indicating that the hU2B0 protein retains its snRNP specificity in the fly+ We also found that the hU2B0 protein is associated with polytene chromosomes (Fig+ 2E), suggesting that hU2B0-containing snRNPs bind nascent transcripts+ Of the five independent transgenic lines carrying the human U1A transgene analyzed, none rescued the lethal null phenotype ( precipitation assay, with the 10E3 monoclonal antibody of O'Connor et al+ (1997), we were able to show that the hU1A protein is expressed in the fly+ As expected, neither U1 snRNA nor U2 snRNA is immunoprecipitated by the 10E3 antibody from control extracts in which no transgene is being expressed (Fig+ 3C, lanes 2, 4)+ In contrast, we were able to immunoprecipitate U1 snRNAs, but not U2 snRNAs, in extracts made from animals bearing the hU1A transgene, using the 10E3 antibody (Fig+ 3C, lanes 3, 5)+ Thus, from these studies, we can conclude that the human U1A protein is expressed in the fly and specifically associates with U1 snRNPs+ Whether the U1A protein is localized appropriately within the cell is not known, because we failed to detect any signal by fluorescent immunolocalization assays even in animals with multiple copies of the hU1A transgene (data not shown)+ Based on our finding that the hU1A and hU2B0 proteins retain their snRNP specificity in the fly, we concluded that the contacts necessary for snRNP specificity are conserved between the mammalian and fly snRNPs and function to control the assembly of these proteins into the appropriate heterologous snRNP+ Nonetheless, expression of the human genes, even together, does not rescue the lethal phenotype of the null allele (data not shown)+ Whether the failure to rescue the lethal phenotype is due to the low level of hU1A expression or due to the absence of a novel, SNF-specific function that cannot be provided by the human proteins remains to be determined+ A five-amino-acid change in the N-terminal RRM changes SNF's snRNP specificity Given that the human proteins retain their snRNP specificity in the fly, it was possible that we could engineer an SNF mutant protein that would no longer incorporate into both snRNPs+ We tested this hypothesis by making a five-amino-acid change in the snf coding region, called the 5MER mutation, that converts the RNAbinding specificity region from a U2B0 motif to a U1A motif (see Figs+ 1 and 2A; VALKT r LVSRS at residues 41-45)+ Based on swap experiments between the human U1A and U2B0 proteins (Scherly et al+, 1990a; Bentley & Keene, 1991) , the snf 5MER mutation is predicted to encode a U1 snRNP-specific protein+ Of the five independent transgenic lines carrying the snf 5MER mutant transgene, one line provided sufficient function to complement the lethal phenotype of snf J210 (Table 1 )+ Interestingly, this line did not rescue the lethality completely, as only 47% of the expected male progeny and 34% of the expected female progeny were recovered ( Together these studies establish that SNF's "RNAspecificity" domain is critical for its dual specificity+ The surprising result that the SNF 5MER protein provides sufficient function to complement the lethal phenotype of the null allele snf J210 strongly suggests that the U2 snRNP does not require the SNF protein to function+ The U2A9 ancillary protein-binding domain is not essential for U2 snRNP incorporation SNF, like U2B0, only binds U2 snRNA when associated with the U2A9 ancillary protein (Polycarpou-Schwarz et al+, 1996)+ However, SNF has only one of the two amino acids important for binding to the U2A9 protein, leading Price et al+ (1998) to suggest that U2A9 binds SNF less tightly than U2B0, allowing SNF to function both as a free protein (i+e+, binding to U1 snRNA) and as a dimer (i+e+, binding to U2 snRNA)+ To investigate whether this domain is critical for SNF's dual snRNP specificity, we made a mutation, E21D, which converts SNF's U2A9-binding site to a U1A-like sequence (Scherly et al+, 1990b )+ The analysis of the SNF E21D protein, however, gave unexpected results+ Eleven independent transgenic lines were obtained, eight of which rescued the lethal null phenotype (Table 1 Our in vivo structure/function studies of the Drosophila U1A/U2B0 homolog, SNF, have revealed an unexpected complexity in the process of snRNP assembly that highlights the difficulty in predicting in vivo phenotypes from in vitro studies+ Although SNF, like its human counterparts, U1A and U2B0, binds specifically to the snRNA stem-loops in vitro, our results suggest that, in the context of a full length protein, RNA binding is not essential for assembly into snRNPs+ We show that in vivo, a snf mutation predicted to eliminate RNA binding, nevertheless assembles into both U1 and U2 snRNPs and retains sufficient function to rescue the lethal phenotype of snf null mutations+ That RNA binding is not essential for snRNP incorporation was also suggested by studies with mammalian cell extracts, where U1A was shown to assemble into U1 snRNPs on U1 snRNA substrates missing stem-loop II + Together these studies suggest that other contacts, mediated by either RNA-protein or protein-protein interactions, are sufficient for snRNP assembly+ Our genetic studies suggest that the C-terminal RRM can compensate for the loss of RNA binding by providing other contacts that hold the protein in snRNPs+ This function is likely to be redundant with that provided by the N-terminal RRM because, in vivo, the C-terminal RRM is dispensable in the presence of a wild-type N-terminal RRM (Flickinger & Salz, 1994 )+ Although redundant, it is unlikely that the C-terminal RRM fulfills its function by binding RNA+ Studies with the C-terminal RRM of the human U1A protein, which is 81% identical to SNF's C-terminal RRM, have shown that it does not bind RNA in vitro (Lu & Hall, 1995) + Based on these studies, we suggest that the function of the C-terminal RRM is to tether the protein in the snRNP via proteinprotein interactions+ Additional evidence that the C-terminal RRM plays a role in snRNP function comes from studies of the Saccharomyces cerevisiae U1A homolog, MUD1p (Liao et al+, 1993; Tang & Rosbash, 1996) + Although MUD1 is a nonessential gene in yeast, a splicing defect can be detected in a mud1 mutant background using a reporter construct with an inefficiently spliced intron+ Using this assay, Tang and Rosbash (1996) found that the C-terminal RRM is important for efficient splicing+ At least in yeast, this function is U1A specific, because the U2B0 homolog, YIB9p, has no C-terminal RRM (Polycarpou-Schwarz et al+, 1996; Tang et al+, 1996; Caspary & Séraphin, 1998 
)+
The RNA-binding specificity region, but not the U2A9-binding motif, is necessary for SNF's dual snRNP specificity A second striking feature of the structure/function results presented here is our finding that the motifs important in determining RNA-binding specificity to the different snRNA stem-loop structures play a role in targeting the protein to the appropriate snRNP+ We were able to establish this in two ways+ First, we showed that the human proteins retained their snRNP specificity in the fly+ Second, we showed that by changing the sequence in the "specificity" region in the fly N-terminal RRM domain to a U1A-like sequence, we were able to transform SNF into a U1 snRNP-specific protein+ RNA target discrimination, therefore, is essential for directing the protein into the appropriate snRNP+ This function is different from the activity destroyed by the RNAbinding mutation, snf R49Q , because the presence of the C-terminal RRM cannot compensate for the mutations in the specificity motif+ In contrast to our success in altering SNF's snRNP specificity by mutating the specificity motif, when we converted SNF's U2A9 protein-binding site to a U1A-like sequence, we found that SNF retained its ability to incorporate into both snRNPs+ This result was surprising because in vitro, SNF only binds to U2 snRNA in the presence of a U2A9-like activity provided by either the human protein or Drosophila nuclear extract (Polycarpou-Schwarz et al+, 1996) + Perhaps the mutation that we made did not destroy the interaction with the Drosophila U2A9 protein+ Alternatively, it is possible that the interaction with the Drosophila U2A9-protein is not essential for U2 snRNP incorporation in vivo+ Now that we have identified the fly homolog of U2A9, we can distinguish between these possibilities (A+ Nagengast & H+ Salz, unpubl+)+
SNF incorporation into U2 snRNPs is not essential for viability
What is the function of SNF in the U1 and U2 snRNPs? Here, we show that SNF is not essential for U2 snRNP function by demonstrating that animals carrying a snf mutation that converts SNF from a bifunctional protein to a U1 snRNP-specific protein are viable+ Rescue by this mutant transgene is not complete, as both males and females are recovered less frequently than expected, suggesting that these animals, nevertheless, have subtle but detectable defects, possibly due to a reduction in the efficiency and/or accuracy of splicing+ Furthermore, the rescued females have tumorous ovaries, a phenotype that is due to abnormal Sex-lethal regulation in the germline (S+ Stitzinger & H+ Salz, unpubl+)+ Previous studies have shown that snf function contributes to the female-specific splicing regulation of Sex-lethal (reviewed by Cline & Meyer, 1996; Lopez, 1998) + Thus, these studies suggest that snf 's presence in the U2 snRNP contributes to Sex-lethal splicing regulation, at least in the germline+ That the absence of SNF/U2B0 from U2 snRNPs causes only subtle defects was also observed in S. cerevisiae (Tang et al+, 1996; Caspary & Séraphin, 1998 )+ Strains lacking the U2B0 homolog, YIB9, are viable but display both a slowgrowth phenotype and a splicing defect+ Together, these studies suggest that the SNF/U2B0 proteins are part of a network of proteins that work together to insure ac-curate and efficient splicing+ Removal of one, or even several, of these proteins may not abolish splicing in vivo and would not be expected to result in a severe mutant phenotype+ It will be interesting to determine if the role of SNF/U1A in U1 snRNPs is essential for the core splicing machinery to function or whether its function, as a U1 snRNP protein, is also to insure accurate and efficient splicing+
MATERIALS AND METHODS
Drosophila stocks
All crosses were carried out at 25 8C on a standard cornmeal, yeast, molasses, agar medium+ The null mutation used in this study, snf J210 , is described in Flickinger and Salz (1994)+ snf J210 is considered an unambiguous null allele because it is a small deletion of the entire open reading frame+ snf JA2 , the deletion allele that encodes a truncated protein missing the C-terminal RRM, is also described in Flickinger and Salz (1994) + Descriptions of other mutations and balancer chromosomes used in this study can found on FlyBase available at http://flybase+bio+indiana+edu (FlyBase, 1999)+
Minigene construction and P element-mediated germline transformation
The snf minigene was constructed by ligating a full length snf cDNA (700 bp) in between 1+8 kb of upstream genomic sequences that contain the snf promoter and 700 bp of downstream genomic sequence (Flickinger & Salz, 1994) and inserted into a CaSpeR transformation vector (Thummel & Pirrotta, 1992 )+ The CaSpeR transformation vector carries a white ϩ (w ϩ ) minigene to recognize and follow the transgene+ Germline transformants were obtained by standard methods (Spradling & Rubin, 1982; Stellar & Pirrotta, 1986 )+ The mutations in the mutant snf minigenes were generated as follows: The E21D, K25R and 5MER mutations were generated by site-directed mutagenesis in the wild-type snf cDNA+ The E21D and K25R mutations was made with the Transformer site-directed mutagenesis kit (Clontech) according to manufacturer's directions using the following mutagenic reverse primers: K25R: 59-catagagcgacctctttagctcc-39 and E21D: 59-tctttagctcgtccttcttgatc-39+ The 5MER mutation was made by a two-step PCR-mediated site-directed mutagenesis using the following internal mutagenic primers: 59-acattctggtctcccg ctcgctcaaaatgcgc-39 (59 primer) and 59-cattttgagcgagcgggag accagaatgtccag-39 (39 primer)+ The R49Q mutation was generated in a snf cDNA already containing an R49H mutation using the Transformer sitedirected mutagenesis kit (Clontech) using the mutagenic primer 59-atgcctggccctgcattttga-39+
To construct C-RRM only , the C-terminal segment of SNF comprising codons 143-217 was amplified by PCR and isolated using the Advantage PCR cloning kit (Clontech)+ PCR amplification and construction of a start site by generating a I143M mutation was carried out simultaneously using the two primers 59-gccgccgaaccccatggtcttcctcacc-39 (59 primer) and 59-tcgatttattctatatagtttaa-39 (39 primer)+ The PCR fragment was then substituted for the snf cDNA to generate the ⌬RRM1 minigene+
The human U1A and U2B0 minigenes were constructed by ligating the full-length human cDNAs (Habets et al+, 1987; Sillekens et al+, 1987) to the promoter containing 1+8 kb of upstream genomic sequences of snf and inserting this promoter-gene fusion into the CaSperR transformation vector (Thummel & Pirrotta, 1992 
Antibodies, Western blot analysis, and immunofluorescence studies
The following antibodies were used: the anti-SNF antibody, mAb4G3, is specific for human U2B0 and SNF (Habets et al+, 1989; Flickinger & Salz, 1994 )+ The anti-U1A antibody, mAb10E3, is specific for human U1A and does not cross react with U2B0 (O'Connor et al+, 1997)+ This antibody does not cross-react with any Drosophila proteins by Western blot analysis, by immunofluorescence, or by immunoprecipitation (data not shown)+ For Western blot analysis, crude protein extracts were prepared from adult animals and transferred to nitrocellulose for blotting as described in Stitzinger et al+ (1999) + Extracts were prepared from animals where the sole source of detectable SNF protein is the P[w ϩ , snf] transgene and ;1+7 fly equivalents per lane were loaded in each lane+ Because all animals carried two copies of the transgene, the relative levels of SNF protein expressed from each transgenic construct can be directly compared+ Salivary glands were collected and processed for wholemount antibody staining and polytene-chromosome staining as described by Salz and Flickinger (1996) + All salivary glands were obtained from animals in a snf mutant background where the only protein detectable by the anti-SNF antibody is expressed from the transgene+ The animals are homozygous for snf JA2 , a viable deletion allele that encodes a protein missing the epitope for the anti-SNF antibody (Flickinger & Salz, 1994 )+ To insure that the maternal contribution of SNF protein is also derived from the transgene, all animals were from a stock homozygous for snf JA2 , P[dhd ϩ ] and the snf mutant transgene in question+ Because the deletion in snf JA2 also removes the dhd gene, which is required for female fertility, an X-linked transgene expressing dhd ϩ is included in the stock+
